Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (1) Blankenstein, Thomas Prof. Dr. (21) Daniel, Peter Prof. Dr. (1) Ittermann, Bernd Dr. (1) Kammertöns, Thomas Dr. (5) Kettenmann, Helmut Prof. Dr. (2) Kopp, Joachim Dr. (1) Ku, Min-Chi Dr. (2) Millward, Jason Dr. (1) Niendorf, Thoralf Prof. Dr. (23) Paul, Friedemann Prof. Dr. med. (2) Pezzutto, Antonio Prof. Dr. (1) Qadri, Fatimunnisa Dr. (1) Schulz-Menger, Jeanette Prof. Dr. (6) Uckert, Wolfgang Prof. Dr. (2) Waiczies, Helmar Dr. (8) Waiczies, Sonia PD Dr. (8) Winter, Lukas Dr. (4) Wolf, Susanne Dr. (2) (-) Bunse, Mario Dr. (1) (-) Willimsky, Gerald Dr. (7) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) (-) Experimentelle Ultrahochfeld-MR (1) Genetik metabolischer und reproduktiver Störungen (2) Magnetic Resonance (1) (-) Molekulare Immunologie und Gentherapie (8) 1997 (1) 1998 (1) 2000 (3) (-) 2002 (1) 2005 (4) (-) 2007 (2) 2008 (2) 2010 (4) 2011 (2) 2012 (2) (-) 2013 (6) 2014 (2) 2015 (4) 2016 (5) 2017 (4) 2018 (7) 2019 (3) 2020 (4) 2021 (1) 2022 (8) 2023 (8) 2024 (1) 9 Ergebnisse: Active Filter: Bunse, Mario Dr.Willimsky, Gerald Dr.Experimentelle Ultrahochfeld-MRMolekulare Immunologie und Gentherapie 200220072013 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel 22. April 2013 / PLoS ONE Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla L. Winter C. Özerdem W. Hoffmann D. Santoro A. Müller H. Waiczies R. Seemann A. Graessl P. Wust T. Niendorf 01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein 01. Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky 05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein 01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein 01. August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder
01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
22. April 2013 / PLoS ONE Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla L. Winter C. Özerdem W. Hoffmann D. Santoro A. Müller H. Waiczies R. Seemann A. Graessl P. Wust T. Niendorf
01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
01. Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
01. August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder